Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres

Abstract The goal of this work is to develop poly(lactide-co-glycolide) (PLGA) nanospheres designed to deliver proteins for extended periods of time. To accomplish this goal a water-in-oil-in-water emulsion technique was conveniently modified. A study was performed to evaluate how the solvent elimination procedure, the copolymer type (different molecular weight and containing either free or esterified carboxyls) and the surfactant Poloxamer 188 affected the properties of the nanoparticles. The size of the nanospheres become larger (from 300 to 600 nm) by increasing the copolymer molecular weight and by the incorporation of Poloxamer 188. The protein loading efficiency varied from 40 to 90%, reaching the maximum values for the formulations made of PLGA with free carboxyls. However, the co-encapsulation of Poloxamer 188 reduced the protein loading. The in vitro protein release rate, was fairly constant after an initial burst release. The release rate was significantly reduced for the copolymer with terminal free carboxyls but was enhanced by the incorporation of Poloxamer 188 in the nanoparticles. No significant aggregation or fragmentation of the encapsulated protein was observed after incubation for 1 month. Consequently, these nanoparticles can be proposed as new controlled release protein delivery systems.

[1]  A. Almeida,et al.  Immune Response to Nasal Delivery of Antigenically Intact Tetanus Toxoid Associated with Poly(l‐lactic acid) Microspheres in Rats, Rabbits and Guinea‐pigs , 1993, The Journal of pharmacy and pharmacology.

[2]  A. Klibanov,et al.  Stability of Proteins and Their Delivery from Biodegradable Polymer Microspheres , 1996 .

[3]  S. Davis,et al.  The preparation and characterization ofpoly(lactide-co-glycolide) microparticles: III. Microparticle/polymer degradation rates and the in vitro release of a model protein , 1994 .

[4]  S. Davis,et al.  Microparticulate absorption from the rat intestine , 1994 .

[5]  B. Gander,et al.  Quality improvement of spray-dried, protein-loaded D,L-PLA microspheres by appropriate polymer solvent selection. , 1995, Journal of microencapsulation.

[6]  Thomas R. Tice,et al.  Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches , 1990 .

[7]  S. Sharif,et al.  A comparison of alternative methods for the determination of the levels of proteins entrapped in poly(lactide-co-glycolide) microparticles , 1995 .

[8]  P. Couvreur,et al.  Characterization of V3 BRU peptide-loaded small PLGA microspheres prepared by a (w1/o)w2 emulsion solvent evaporation method , 1994 .

[9]  R. Jerome,et al.  Polylactide Microparticles Prepared by Double Emulsion-Evaporation: II. Effect of the Poly(Lactide-co-Glycolide) Composition on the Stability of the Primary and Secondary Emulsions , 1995 .

[10]  W. Koff,et al.  The preparation, characterization and pre-clinical evaluation of an orally administered HIV-I vaccine, consisting of a branched peptide immunogen entrapped in controlled release microparticles , 1995 .

[11]  R. Gupta,et al.  Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. , 1994, Vaccine.

[12]  H. Sah,et al.  Continuous release of proteins from biodegradable microcapsules and in vivo evaluation of their potential as a vaccine adjuvant , 1995 .

[13]  Yoshiaki,et al.  Biodegradable submicron carriers for peptide drugs : Preparation of DL-lactide/glycolide copolymer(PLGA)nanospheres with nafarelin acetate by a novel emulsion-phase separation method in an oil system. , 1995 .

[14]  M. Alonso.  Nanoparticulate Drug Carrier Technology , 1996 .

[15]  R. Jerome,et al.  Effect of the emulsion stability on the morphology and porosity of semicrystalline poly l-lactide microparticles prepared by w/o/w double emulsion-evaporation , 1994 .

[16]  T. Kissel,et al.  Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. , 1992, Vaccine.

[17]  D. McCarthy,et al.  Nanosphere and microsphere uptake via Peyer's patches: observation of the rate of uptake in the rat after a single oral dose , 1992 .

[18]  G W Halbert,et al.  The Uptake and Translocation of Latex Nanospheres and Microspheres after Oral Administration to Rats , 1989, The Journal of pharmacy and pharmacology.

[19]  A. Florence,et al.  Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency , 1990, The Journal of pharmacy and pharmacology.

[20]  T. Kissel,et al.  INJECTABLE BIODEGRADABLE MICROSPHERES FOR VACCINE DELIVERY , 1996 .

[21]  J. Holmgren,et al.  Cholera toxin B subunit (CTB) entrapped in microparticles shows comparable immunogenicity to CTB mixed with whole cholera toxin following oral immunization , 1995 .